All the news Showing 10 of 21 articles from: Life after the cureGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Immune system does not recover despite cured hepatitis C infection Karolinska Institutet / 13 June 2018 Do fatigue and quality of life improve after hepatitis C is cured? Keith Alcorn / 15 May 2018 Patient-reported outcomes such as fatigue, vitality and mental health improve substantially in the two years following hepatitis C cure for people with cirrhosis, but people with cirrhosis are less likely ... Does portal hypertension always improve after hepatitis C cure? Keith Alcorn / 10 May 2018 Although portal hypertension improves in the majority of people with hepatitis C and cirrhosis after hepatitis C is cured, not all people experience improvement, and oesophageal varices may continue to ... Curing hepatitis C reduces deaths and liver disease Keith Alcorn / 17 April 2018 Curing hepatitis C infection significantly reduces deaths from liver disease and reduces the incidence of decompensation, two large prospective studies from Italy and Scotland show. The findings were presented on ... Australian experience shows that use of DAAs can virtually eliminate HCV among prisoners Michael Carter / 19 March 2018 Hepatitis C virus (HCV) infection can be rapidly eliminated in prison populations with the use of direct-acting antivirals (DAAs), results of an Australian study published in Clinical Infectious Diseases suggests. ... Severe fibrosis improves in most people after hepatitis C cure but persists in a quarter Michael Carter / 18 February 2018 Hepatitis C virus (HCV)-related liver fibrosis improves significantly in the majority of people with pre-treatment advanced fibrosis or cirrhosis after treatment resulting in a sustained virological response (SVR), Swedish investigators ... Hepatitis C virus reinfection is uncommon after being cured with DAAs Liz Highleyman / 22 May 2017 Most people on opiate substitution therapy were successfully treated for hepatitis C with an interferon-free regimen of grazoprevir/elbasvir (Zepatier), and only a small number became reinfected during three years of follow-up, researchers reported ... HCV treatment allows one in four people to come off the transplant waiting list Keith Alcorn / 24 April 2017 Around one in four people with hepatitis C and decompensated cirrhosis came off the transplant waiting list in Europe after direct-acting antiviral treatment, and very few had any subsequent liver-related ... Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer? Liz Highleyman / 27 February 2017 People with HIV and hepatitis C virus (HCV) co-infection who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have an increased likelihood of developing hepatocellular ... People with HCV attaining SVR continue to have increased mortality risk but this is due to alcohol and drug use Michael Carter / 03 October 2016 Mortality rates among people with hepatitis C virus (HCV) who attain a sustained virological response after HCV treatment are approximately twice as high as those expected in the general population, Scottish investigators report ... ← Prev123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive